Dr. Rapundalo, has broad experience in the life sciences, with an extensive background in pharmaceutical research and development. Prior to joining MichBio in April 2006, he spent almost 20 years as a senior research scientist, project manager, and group leader with Parke-Davis Pharmaceutical Research and then Pfizer, Inc., primarily in... Read More

Jay is an associate director at AbbVie Ventures, which invests in novel, transformational therapeutics across oncology, immunology, and neuroscience at discovery and pre-clinical stages. Prior to AbbVie Ventures, Jay worked at ZS Associates where he advised clients across the healthcare industry on corporate and commercial strategies. He has also worked... Read More

Dr. Scott Merz, Ph.D. co-founded MC3 Inc. in 1991 and serves as its Chief Executive Officer and President. He has extensive experience in all aspects of the medtech industry over the 25 years including technology startup, research and development, regulatory, fundraising and partnering. He has negotiated several licensing and other... Read More

Scott joined the team in June 2017. In the current health care business and economic climate, successful organizations have to be cognizant of disruptive threats that place the core business at risk and act on both short-term and long-range investment opportunities to counteract these forces. In his position at SHV,... Read More

Dr. Rapundalo, has broad experience in the life sciences, with an extensive background in pharmaceutical research and development. Prior to joining MichBio in April 2006, he spent almost 20 years as a senior research scientist, project manager, and group leader with Parke-Davis Pharmaceutical Research and then Pfizer, Inc., primarily in... Read More

Michael Temple is a partner in the Corporate and Securities Practice Group of the Commercial Department of Pepper Hamilton LLP, resident in the Detroit office. Mr. Temple concentrates his practice in the formation and operations of Small Business Investment Companies (SBICs) and other private funds, including with respect to SBIC... Read More

Calvin is a Venture Partner on the NCT Ventures investment team and focuses on identifying and evaluating new investment opportunities, market and competitive intelligence, strategy, fundraising, portfolio management, and diversity & underserved market initiatives. He represents NCT on the Board of Directors of portfolio companies including SafeChain and Kare Intellex.... Read More

Dr. Adriaens is the Professor of Civil and Environmental Engineering and Professor of Entrepreneurship and Strategy in the Ross School of Business at University of Michigan. Dr. Adriaens is a Co-Developer of the KeyStone Compact. He co-founded Water Risk Analytics. His current work focuses on CleanTech innovation … and entrepreneurship.... Read More

SafeChain believes that property transactions should be seamless and completed within a matter of seconds. The groundbreaking application of blockchain technology within the software behind SafeChain prevents fraud in real estate transactions. Prior to SafeChain, Rob was the former Executive Director at JP Morgan Chase & Co. His experience while... Read More

Sam Savant is the Founder and CEO of TwoScoreTwo – The Blockchain Commerce Company. Sam has 15 plus years experience working with global supply chains in companies like XPO and Ryder.  Prior to launching TwoScoreTwo, Sam was the Director of Innovation and Product Development at Ryder.  His experience spans Technology... Read More